Should You Buy BioCardia Inc (BCDA) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
Not a good buy right now for a beginner long-term investor with $50k–$100k who wants to deploy capital immediately. BCDA is in a clear bearish technical trend, has no near-term news catalysts, and the latest quarter (2025/Q3) shows continued losses with zero revenue—making the risk/reward unattractive versus more stable long-term holdings.
Technical Analysis
Trend is bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating sustained downward pressure. MACD histogram is negative (-0.00086) and negatively expanding, which supports weakening momentum. RSI_6 at ~44.5 is neutral (not oversold), so there is no strong mean-reversion buy signal. Price (1.32) is below the pivot (1.354), with nearby support at S1=1.296 then S2=1.261; resistance levels are R1=1.411 and R2=1.446. With no proprietary buy signals today, the technical setup does not favor an immediate long-term entry.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so a Wall Street pros/cons summary cannot be validated from the dataset. Based on the available fundamentals/technicals alone: pros are limited (no clear trend reversal signals); cons include ongoing losses, zero revenue, and a bearish chart.
Wall Street analysts forecast BCDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BCDA is 15.5 USD with a low forecast of 6 USD and a high forecast of 25 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast BCDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BCDA is 15.5 USD with a low forecast of 6 USD and a high forecast of 25 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 1.300
Current: 1.300
No data
